Genesys International Corporation Limited (NSE:GENESYS)
India flag India · Delayed Price · Currency is INR
672.80
-5.75 (-0.85%)
Apr 3, 2025, 3:30 PM IST

NSE:GENESYS Statistics

Total Valuation

NSE:GENESYS has a market cap or net worth of INR 26.80 billion. The enterprise value is 27.38 billion.

Market Cap 26.80B
Enterprise Value 27.38B

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date May 30, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +8.10%
Shares Change (QoQ) -1.42%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 16.25M

Valuation Ratios

The trailing PE ratio is 51.42.

PE Ratio 51.42
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 8.95
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 52.53
EV / Sales 9.51
EV / EBITDA 22.69
EV / EBIT 35.25
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.14
Debt / EBITDA 0.61
Debt / FCF n/a
Interest Coverage 10.89

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 9.49%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 2.91M
Profits Per Employee 525,999
Employee Count 991
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +6.56% in the last 52 weeks. The beta is 0.48, so NSE:GENESYS's price volatility has been lower than the market average.

Beta (5Y) 0.48
52-Week Price Change +6.56%
50-Day Moving Average 766.64
200-Day Moving Average 780.28
Relative Strength Index (RSI) 38.30
Average Volume (20 Days) 301,143

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:GENESYS had revenue of INR 2.88 billion and earned 521.27 million in profits. Earnings per share was 12.95.

Revenue 2.88B
Gross Profit 1.53B
Operating Income 776.83M
Pretax Income 752.60M
Net Income 521.27M
EBITDA 1.18B
EBIT 776.83M
Earnings Per Share (EPS) 12.95
Full Income Statement

Balance Sheet

The company has 169.75 million in cash and 734.30 million in debt, giving a net cash position of -564.55 million.

Cash & Cash Equivalents 169.75M
Total Debt 734.30M
Net Cash -564.55M
Net Cash Per Share n/a
Equity (Book Value) 5.12B
Book Value Per Share 127.21
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 53.15%, with operating and profit margins of 26.97% and 18.10%.

Gross Margin 53.15%
Operating Margin 26.97%
Pretax Margin 26.13%
Profit Margin 18.10%
EBITDA Margin 40.88%
EBIT Margin 26.97%
FCF Margin n/a

Dividends & Yields

NSE:GENESYS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.10%
Shareholder Yield -8.10%
Earnings Yield 1.94%
FCF Yield n/a

Stock Splits

The last stock split was on June 23, 2010. It was a forward split with a ratio of 2.

Last Split Date Jun 23, 2010
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a